Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolcapone in Frontotemporal Dementia
NCT00604591Phase 2Completed
- Sponsor
- Columbia University
- Start
- Jan 2008
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolcapone in frontotemporal dementia (FTD), sponsored by Columbia University. Started Jan 2008; status: completed.
02
Drugs
tolcapone
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT00604591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604591.